tyloxapol has been researched along with pravastatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, S; Furukawa, S; Hirano, T; Iwai, M; Kazumi, T; Matsuba, K; Matsushita, M; Morita, M; Yoshino, G | 1 |
| Ito, T; Shiomi, M | 1 |
2 other study(ies) available for tyloxapol and pravastatin
| Article | Year |
|---|---|
Effect of pravastatin on newly-secreted very low density lipoprotein composition in rats.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Chylomicrons; Heptanoic Acids; Lipoproteins, VLDL; Male; Naphthalenes; Phospholipids; Polyethylene Glycols; Pravastatin; Rats; Rats, Inbred Strains; Triglycerides | 1991 |
Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
Topics: Animals; Cholesterol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Injections, Intravenous; Lipids; Lipoproteins; Lipoproteins, VLDL; Liver; Male; Particle Size; Polyethylene Glycols; Pravastatin; Rabbits | 1994 |